炎症小体在对乙酰氨基酚诱导的肝损伤和急性肝衰竭中的作用
对乙酰氨基酚过量是急性肝衰竭的首位病因,N-乙酰半胱氨酸在毒性初升前给药有效,但许多患者就诊时已过此阶段。本文综述小鼠和人类对乙酰氨基酚肝损伤机制,重点讨论炎症及炎症小体的作用,特别是Nalp3炎症小体形成与晚期毒性直接相关。
要点
- 对乙酰氨基酚过量是急性肝衰竭首位病因,发病率和死亡率高。
- N-乙酰半胱氨酸在毒性初升前给药是有效解毒剂,但许多患者就诊时已过此阶段。
- Nalp3炎症小体形成与晚期对乙酰氨基酚毒性直接相关。
核心结论
- 对乙酰氨基酚诱导的晚期急性肝衰竭亟需有效治疗,炎症小体激活可能是介导晚期损伤的关键炎症过程。
研究设计与样本
- 综述,讨论小鼠和人类对乙酰氨基酚诱导肝损伤的机制,重点聚焦炎症和炎症小体的作用。
主要发现
- 药物诱导的急性肝衰竭发病率和死亡率高,对乙酰氨基酚过量是急性肝衰竭的首位病因。
- N-乙酰半胱氨酸在毒性初升前给药是有效解毒剂,但许多患者就诊时已过此阶段。
- 文献中就是否存在由炎症过程介导的第二阶段损伤存在争论。
- caspase-1和白细胞介素-1β的激活由称为炎症小体的分子复合物介导,是这一潜在炎症过程的关键。
- 已鉴定出多种不同刺激可形成多种不同的炎症小体复合物,其中含NACHT、富亮氨酸重复(LRR)和pyrin(PYD)结构域的蛋白3(Nalp3)炎症小体的形成已直接归因于晚期对乙酰氨基酚毒性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Drug-induced acute liver failure carries a high morbidity and mortality rate. Acetaminophen overdose is the number one cause of acute liver failure and remains a major problem in Western medicine. Administration of N-acetyl cysteine is an effective antidote when given before the initial rise in toxicity; however, many patients present to the hospital after this stage occurs. As such, treatments which can alleviate late-stage acetaminophen-induced acute liver failure are imperative. While the initial mechanisms of toxicity are well described, a debate has recently occurred in the literature over whether there is a second phase of injury, mediated by inflammatory processes. Critical to this potential inflammatory process is the activation of caspase-1 and interleukin-1β by a molecular complex known as the inflammasome. Several different stimuli for the formation of multiple different inflammasome complexes have been identified. Formation of the NACHT, leucine-rich repeat (LRR) and pyrin (PYD) domains-containing protein 3 (Nalp3) inflammasome in particular, has directly been attributed to late-stage acetaminophen toxicity. In this review, we will discuss the mechanisms of acetaminophen-induced liver injury in mice and man with a particular focus on the role of inflammation and the inflammasome.
引用
- Woolbright BL, Jaeschke H. Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure. J Hepatol. 2016. PMID: 27913221. doi:10.1016/j.jhep.2016.11.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。